Parallel import companies have discovered four falsified batches of cancer medication, Velcade, in the Dutch and Danish supply chain. Danish company, Abacus Medicines, intercepted three batches of Velcade 3.5mg/vial – with the numbers GGZT800 (expiry date 06/2019), GCZTQ00 (02/2019) and FGZSL01 (06/2018) – while Dutch firm, Axicorp Pharma BV, identified a fourth batch FJZT800 with an expiry of 09/2018. According to the German health agency, the falsified vials present variations in the vial type and seal. The batches mimic the genuine product distributed in Bulgaria and Romania, but the folding carton, vial labels and package inserts are all forged. Laboratory testing indicates, however, that the vials contain an active ingredient at the levels and specifications indicated on the label. This would suggest that the culprits were repackaging expired products or sourcing cheaper generic versions of the medication.
Source : www.securingindustry.com